Interaction between APOE Ɛ4 status, chemotherapy and endocrine therapy on cognitive functioning among breast cancer survivors: the CANTO-Cog longitudinal study

Abstract Background Apolipoprotein Ɛ4 genotype (APOE4) has been associated with cancer-related cognitive impairment, but its interaction with treatments remains unclear. This longitudinal study aims to evaluate the association between APOE4 and cognitive impairment in women with breast cancer (BC) u...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mylène Duivon, François Christy, Emilie Thomas, Justine Lequesne, Hélène Castel, Catherine Gaudin, Dominique Delmas, Sandrine Boyault, Olivier Rigal, Chayma Bousrih, Christelle Lévy, Florence Lerebours, Antonio Di Meglio, Patricia A. Ganz, Kathleen Van Dyk, Ines Vaz Luis, Marie Lange, Florence Joly
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2025-02-01
coleção:	Breast Cancer Research
Assuntos:	Breast cancer APOE4 Cancer-related cognitive impairment Endocrine therapy Chemotherapy
Acesso em linha:	https://doi.org/10.1186/s13058-025-01974-2
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!